Status:
RECRUITING
The Effectiveness of Temple Stay in Irritable Bowel Syndrome
Lead Sponsor:
DongGuk University
Conditions:
Irritable Bowel Syndrome
Microbial Colonization
Eligibility:
All Genders
20-69 years
Brief Summary
This research is a clinical trial aimed at improving the gut microbiome of patients with Irritable Bowel Syndrome (IBS) through a temple stay experience. Participants in the study are expected to par...
Detailed Description
Irritable Bowel Syndrome (IBS) is a syndrome characterized by recurrent abdominal pain accompanied by abdominal discomfort, changes in bowel habits, and abdominal bloating. It is a common condition, a...
Eligibility Criteria
Inclusion
- Patients aged 20-69 with diarrhea-predominant irritable bowel syndrome
Exclusion
- Monk
- history of irritable bowel syndrome (constipation-predominant), history of inflammatory bowel disease, history of colorectal cancer, history of gastrointestinal resection,
- abnormal blood test (liver function test: AST or ALT more than 1.5 times the normal limit, total bilirubin increase of more than 1.5mg/dL, CCr \< 30 mL/min, platelets less than 100,000, PT/aPTT increase of more than 20% of the normal upper limit),
- uncontrolled hypertension and diabetes
Key Trial Info
Start Date :
July 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05999500
Start Date
July 1 2023
End Date
December 31 2024
Last Update
May 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dongguk University Ilsan Hospital
Goyang-si, Gyeonggi-do, South Korea, 10326